CD40LG and metabolic dysfunction-associated steatotic liver disease: The proportions of patients with AST or ALT >ULN, ALP >1.5×ULN, serum IgM >ULN, and combined NAFLD in the PBC plus hyperlipidemia group were significantly higher than those in the non-hyperlipidemia group (all P<0.01).